Zobrazeno 1 - 10 of 23 pro vyhledávání: '"Ana S. Pitiot"'
2
TP53 p.R72P genotype is a marker of poor prognosis in lung cancer
Autor: Aurora Astudillo, Adonina Tardón, Ana S. Pitiot, Milagros Balbín, Mirko Peter Neumann, Cristina Martínez, Íñigo Santamaría, María Victoria González
Publikováno v: Cancer Biomarkers. 21:747-754
Background Lung cancer is a leading cause of death worldwide, with poor survival rates despite diagnostic and therapeutic advances. Markers are needed in order to improve clinical patient management and survival. TP53 is frequently involved in lung c
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::520fcb92a9c3719822e167183724376b
https://doi.org/10.3233/cbm-170230
Zobrazit plný text záznamu
4
Transplacental transfer of essential thrombocythemia in monozygotic twins
Autor: Ana S. Pitiot, Xose S. Puente, Sara Muñiz Lobato, Íñigo Santamaría, Rafael Valdés-Mas, Milagros Balbín, Jesús Gutiérrez-Abril, Diana A. Puente
Publikováno v: Blood. 128:1894-1896
To the editor: Essential thrombocythemia (ET), polycythemia vera, and primary myelofibrosis constitute a group of hematological disorders classically identified as BCR-ABL –negative myeloproliferative neoplasms (MPNs).[1][1],[2][2] Our understandin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5f4f959f007517fc30a4a326aa87e020
https://doi.org/10.1182/blood-2016-06-724252
Zobrazit plný text záznamu
5
Identification of somatic and germ-line DICER1 mutations in pleuropulmonary blastoma, cystic nephroma and rhabdomyosarcoma tumors within a DICER1 syndrome pedigree
Autor: Pilar Blay, Soledad Fernández, Héctor Torres, Marta G. Alvarado, Íñigo Santamaría, Lorena Fernández-Martínez, Ana S. Pitiot, Ángeles Paredes, José Antonio Villegas, Milagros Balbín
Publikováno v: Scopus
BMC Cancer
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
Background DICER1 syndrome is a pediatric cancer predisposition condition causing a variety of tumor types in children and young adults. In this report we studied a family with two relatives presenting a variety of neoplastic conditions at childhood.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::322300b3b8e2cbe483a1318d649db5ce
https://doi.org/10.1186/s12885-017-3136-5
Zobrazit plný text záznamu
6
A t(1;9) translocation involving CSF3R as a novel mechanism in unclassifiable chronic myeloproliferative neoplasm
Autor: Ana Gutiérrez-Fernández, Jesús Gutiérrez-Abril, Ana S. Pitiot, Ángel Alvarez-Eguiluz, Íñigo Santamaría, Milagros Balbín, Soledad González-Muñiz, Carmen Sanzo, Xose S. Puente, Jose Maria Vicente
Publikováno v: Scopus
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
This work was funded by the Spanish Ministry of Economy and Competitiveness (grant SAF2013-45836-R). J.G-A. is supported by a fellowship from the Spanish Ministry of Education. We thank Fundación Caja Rural de Asturias for financial collaborative su
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8a8394c66dfd947ff4436ab0a25368a
http://hdl.handle.net/10651/46081
Zobrazit plný text záznamu
7
Role of VHL, HIF1A and SDH on the expression of miR-210: implications for tumoral pseudo-hypoxic fate
Autor: Bartolomé Scola, Milagros Balbín, Aurora Astudillo, Anna Merlo, Raquel del Toro, Ana S. Pitiot, Nuria Valdés, José I. Piruat, Inés Sáenz-de-Santa-María, Simón Méndez-Ferrer, Cristóbal Bernardo-Castiñeira, Carlos Suárez, María-Dolores Chiara
Publikováno v: Scopus
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
Oncotarget
RUO: Repositorio Institucional de la Universidad de Oviedo
Universidad de Oviedo (UNIOVI)
Digital.CSIC. Repositorio Institucional del CSIC
Repisalud
Instituto de Salud Carlos III (ISCIII)
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
The hypoxia-inducible factor 1α (HIF-1α) and its microRNA target, miR-210, are candidate tumor-drivers of metabolic reprogramming in cancer. Neuroendocrine neoplasms such as paragangliomas (PGLs) are particularly appealing for understanding the can
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d93c72ffe6eff5872ebb199445500026
http://hdl.handle.net/10651/42408
Zobrazit plný text záznamu
8
Identification of SomaticVHLGene Mutations in Sporadic Head and Neck Paragangliomas in Association With Activation of the HIF-1α/miR-210 Signaling Pathway
Autor: Miguel Arístegui, Inés Saenz de Santa-María, Sandra Bernaldo de Quirós, Carlos Suárez, María-Dolores Chiara, Bartolomé Scola, Ana S. Pitiot, Anna Merlo, Aurora Astudillo, Miquel Quer, Milagros Balbín
Publikováno v: The Journal of Clinical Endocrinology & Metabolism. 98:E1661-E1666
Head and neck paragangliomas (HNPGLs) arise from parasympathetic paraganglias and 35% to 45% are hereditary caused by mutations in succinate dehydrogenase (SDH) genes. The connection between SDH and tumor development is unclear. The most accepted hyp
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9828420a4179c33959bea7e9b57a1e4b
https://doi.org/10.1210/jc.2013-1636
Zobrazit plný text záznamu
9
Loss of collagenase-2 confers increased skin tumor susceptibility to male mice
Autor: Milagros Balbín, Alberto M. Pendás, Carlos López-Otín, Christopher M. Overall, Aurora Astudillo, Ana S. Pitiot, Steven D. Shapiro, Antonio Fueyo, Angus M. Tester
Publikováno v: Nature Genetics. 35:252-257
Matrix metalloproteinases (MMPs) have fundamental roles in tumor progression, but most clinical trials with MMP inhibitors have not shown improvements in individuals with cancer. This may be partly because broad-range inhibitors also reduce host-prot
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e683d240639896e4e6e2862aa531743b
https://doi.org/10.1038/ng1249
Zobrazit plný text záznamu
10
Germ-line mutations in epidermal growth factor receptor (EGFR) are rare but may contribute to oncogenesis: A novel germ-line mutation in EGFR detected in a patient with lung adenocarcinoma
Autor: Aurora Astudillo, Patricia González-Arriaga, Primitiva Menéndez, Fernando Iglesias, José M. Freije, Adonina Tardón, Ana S. Pitiot, Milagros Balbín, Fernando G. Osorio, Íñigo Santamaría, Pilar Blay, Irene Centeno
Publikováno v: RUO. Repositorio Institucional de la Universidad de Oviedo
instname
BMC Cancer
BMC Cancer, Vol 11, Iss 1, p 172 (2011)
Background A subset of lung cancer patients harbour EGFR somatic mutations in their tumours and are candidates for treatment with EGFR tyrosine kinase inhibitors. In a few cases EGFR mutations have also been found in the germ line, suggesting a role
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86426ddc93830765ded608e96c1d89df
http://hdl.handle.net/10651/6393
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje